Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models
The Korean Journal of Physiology & Pharmacology · 01.01.2026 · 30 (1) · 41-48
DOI: 10.4196/kjpp.25.355 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Korean Journal of Physiology & Pharmacology, online erschienen am 01.12.2025. Verfasst von Jihwan Moon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
- Department of Biochemistry, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
- Department of Global Medical Science, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
- ONCOin, Ltd., Chuncheon 24341, Korea.
Zitieren
APA
Moon, J., Vo, V. T. A., Nhat, L. T., Eom, M., & Jeong, Y. (2026). Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models. The Korean Journal of Physiology & Pharmacology, 30(1), 41-48. https://doi.org/10.4196/kjpp.25.355
Vancouver
Moon J, Vo VTA, Nhat LT, Eom M, Jeong Y. Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models. The Korean Journal of Physiology & Pharmacology. 2026;30(1):41-48. doi:10.4196/kjpp.25.355
BibTeX
@article{Moon2026,
author = {Moon, Jihwan and Vo, Vu T A and Nhat, Le Tran and Eom, Minseob and Jeong, Yangsik},
title = {Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models},
journal = {The Korean Journal of Physiology & Pharmacology},
year = {2026},
volume = {30},
number = {1},
pages = {41--48},
doi = {10.4196/kjpp.25.355}
}
EUVIMED